Advances in secondary prevention: Optimising cardiometabolic risks
15 Oct 2024
Cardiovascular Professional Care Theatre
Sponsorship of this congress is initiated, developed and funded by © Amarin Pharmaceuticals Ireland Limited
This session will delve into evidence-based approaches to managing secondary prevention in cardiovascular disease, empowering primary care providers to reduce CV risk and improve long-term patient health.
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.jpg/fit-in/1280x9999/filters:no_upscale()){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
)
){kind=logo}
){kind=logo}
